2014, Número 2
Endocarditis infecciosa
Idioma: Español
Referencias bibliográficas: 46
Paginas: 76-83
Archivo PDF: 346.05 Kb.
RESUMEN
La EI (endocarditis infecciosa) es una enfermedad cuya incidencia es de 3 a 9 casos por cada 100,000 habitantes en países industrializados. La población más vulnerable son las personas de edad avanzada y sexo femenino. La EI se define como una infección que puede afectar a distintos sitios del corazón, como válvulas cardiacas, defectos septales, cuerdas tendinosas y endoncardio. Se calcula que la EI afecta en 77% de los casos a válvulas nativas, de las cuales el 43.3% son válvulas mitrales y 26.3% válvulas de la aórtica. Los principales microorganismos causantes de la EI son estafilococos, estreptococos y enterococos. Su diagnóstico se realiza principalmente por clínica, con apoyo de estudios de laboratorio y ecocardiográficos. La estrategia de manejo incluye medidas farmacológicas con antibióticos bactericidas de primera elección y procedimientos quirúrgicos.REFERENCIAS (EN ESTE ARTÍCULO)
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009; 30 (19): 2369-2413. doi: 10.1093/eurheartj/ehp285.
Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr., Bayer AS et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of Internal Medicine. 2009; 169 (5): 463-473. doi: 10.1001/archinternmed.2008.603. PubMed PMID: 19273776; PubMed Central PMCID: PMC3625651.
Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007; 116 (15): 1736-1754. doi: 10.1161/CIRCULATIONAHA.106.183095. PubMed PMID: 17446442.
Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW, O’Gara PT et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008; 118 (8): 887-896. doi: 10.1161/CIRCULATIONAHA.108.190377. PubMed PMID: 18663090.
Fernández-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008; 47 (10): 1287-97. doi: 10.1086/592576. PubMed PMID: 18834314.
Gould FK, Denning DW, Elliott TS, Foweraker J, Perry JD, Prendergast BD et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. The Journal of Antimicrobial Chemotherapy. 2012; 67 (2): 269-89. doi: 10.1093/jac/dkr450. PubMed PMID: 22086858.
Baron EJ, Scott JD, Tompkins LS. Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures. Clinical infectious diseases. Infectious Diseases Society of America. 2005; 41 (11): 1677-1680. doi: 10.1086/497595. PubMed PMID: 16267743.
Petti CA, Bhally HS, Weinstein MP, Joho K, Wakefield T, Reller LB et al. Utility of extended blood culture incubation for isolation of Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella organisms: a retrospective multicenter evaluation. Journal of Clinical Microbiology. 2006; 44 (1): 257-259. doi: 10.1128/JCM.44.1.257-259.2006. PubMed PMID: 16390985; PubMed Central PMCID: PMC1351967.
Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2010; 51 (2): 131-140. doi: 10.1086/653675. PubMed PMID: 20540619.
Leli C, Moretti A, Pasticci MB, Cenci E, Bistoni F, Mencacci A. A commercially available multiplex real-time PCR for detection of pathogens in cardiac valves from patients with infective endocarditis. Diagnostic Microbiology and Infectious Disease. 2014; 79 (1): 98-101. doi: 10.1016/j.diagmicrobio.2013.12.011. PubMed PMID: 24731762.
Bekeris LG, Tworek JA, Walsh MK, Valenstein PN. Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Archives of Pathology & Laboratory Medicine. 2005; 129 (10): 1222-1225. doi: 10.1043/1543-2165(2005)129[1222:TIBCCA]2.0.CO;2. PubMed PMID: 16196507.
Self WH, Mickanin J, Grijalva CG, Grant FH, Henderson MC, Corley G et al. Reducing blood culture contamination in community hospital emergency departments: a multicenter evaluation of a quality improvement intervention. Academic emergency medicine. Journal of the Society for Academic Emergency Medicine. 2014; 21 (3): 274-282. doi: 10.1111/acem.12337. PubMed PMID: 24628752; PubMed Central PMCID: PMC3984048.
Durack DT, Pelletier LL, Petersdorf RG. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. The Journal of Clinical Investigation. 1974; 53 (3): 829-833. doi: 10.1172/JCI107622. PubMed PMID: 4492776; PubMed Central PMCID: PMC333064.
Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008; 46 (2): 232-242. doi: 10.1086/524666. PubMed PMID: 18171255.
Cosgrove SE, Vigliani GA, Fowler VG Jr., Abrutyn E, Corey GR, Levine DP et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2009; 48 (6): 713-721. doi: 10.1086/597031. PubMed PMID: 19207079.
Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Bolger AF, Levison ME et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005; 111 (23): e394-434. doi: 10.1161/CIRCULATIONAHA.105.165564. PubMed PMID: 15956145.
Misfeld M, Girrbach F, Etz CD, Binner C, Aspern KV, Dohmen PM et al. Surgery for infective endocarditis complicated by cerebral embolism: A consecutive series of 375 patients. The Journal of Thoracic and Cardiovascular Surgery. 2014; 147 (6): 1837-1846. doi: 10.1016/j.jtcvs.2013.10.076. PubMed PMID: 24837722.
Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. European Heart Journal. 2007; 28 (9): 1155-1161. doi: 10.1093/eurheartj/ehm005. PubMed PMID: 17363448.